LONDON (Reuters) - A Philadelphia jury on Tuesday committed Johnson & Johnson to $ 8 billion in compensation for an American man who alleged that a drug made by Jansen Pharmaceuticals of the same company caused his breasts to grow.
Nicholas Murray of Philadelphia, Pennsylvania, filed a lawsuit against the famous company, claiming that the company did not warn customers about the complications of the drug "Risperdal" psychotherapy, which Nicholas has been taking since he was a child to help him sleep, where he was suffering from injury With autism.
However, the drug, according to Forbes, "led to an increase in the size of Nicholas chest, a complication that the company did not warn about.
Although Johnson & Johnson previously objected in 2015 to the first judgment in the case, the company paid $ 1.75 million, before the value was later reduced to $ 680,000, but now, with a new court ruling, Nicholas has received a massive $ 8 billion .
Commenting on the new ruling, the company's representatives said: "The value of compensation is not equal to the previous value of $ 680 thousand, and the company is confident that the verdict will be canceled, because it is unfounded."
Johnson & Johnson has faced numerous lawsuits and complaints after linking its flagship products, baby powder, to cancer.